KR920019740A - 약학적 화합물 - Google Patents

약학적 화합물 Download PDF

Info

Publication number
KR920019740A
KR920019740A KR1019920006703A KR920006703A KR920019740A KR 920019740 A KR920019740 A KR 920019740A KR 1019920006703 A KR1019920006703 A KR 1019920006703A KR 920006703 A KR920006703 A KR 920006703A KR 920019740 A KR920019740 A KR 920019740A
Authority
KR
South Korea
Prior art keywords
enyl
prop
urea
hydroxy
fluorophenyl
Prior art date
Application number
KR1019920006703A
Other languages
English (en)
Inventor
알란 하이트 게리
데이비드 마이엘리치 에드워드
웰스 스나이더 데이비드
슈와레쯔 툴리오
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR920019740A publication Critical patent/KR920019740A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/47—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

약학적 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기 일반식(I)의 N-하이드록시-N-[3-[2-(할로페닐티오)페닐]프로프-2-에닐]우레아 및 그의 약학적으로 허용되는 염.
    상기식에서, R1은 수소 또는 할로이고, X는 플루오로 또는 클로로이다.
  2. 제1항에 있어서, N-하이드록시-N-[3-[2-(4-플루오로페닐티오)-6-플루오로페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-플루오로페닐티오)-5-플루오로페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-플루오로페닐티오)-4-플루오로페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-플루오로페닐티오)-3-플루오로페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-클로로페닐티오)-6-플루오로페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-클로로페닐티오)-3-플루오로페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-클로로페닐티오)페닐]프로프-2-에닐]우레아 ; N-하이드록시-N-[3-[2-(4-플루오로페닐티오)페닐]프로프-2-에닐]우레아 및 그의 약학적으로 허용되는 염 중에서 선택된 화합물.
  3. 활성 성분으로서의 제1항 또는 제2항에 따른 화합물을 하나 이상의 약학적으로 허용되는 담체, 희석제 또는 부형제와 함께 포함하는, 천식치료용, 관절염치료용, 건선치료용, 항알러지성, 허혈치료용, 염증성 장 질환치료용 또는 성인 호흡 곤란 증후군 치료용 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920006703A 1991-04-23 1992-04-21 약학적 화합물 KR920019740A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69020491A 1991-04-23 1991-04-23
US690,204 1991-04-23

Publications (1)

Publication Number Publication Date
KR920019740A true KR920019740A (ko) 1992-11-19

Family

ID=24771539

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920006703A KR920019740A (ko) 1991-04-23 1992-04-21 약학적 화합물

Country Status (17)

Country Link
US (1) US5283361A (ko)
EP (1) EP0510948A1 (ko)
JP (1) JPH05117227A (ko)
KR (1) KR920019740A (ko)
CN (1) CN1066062A (ko)
AU (1) AU638641B2 (ko)
BR (1) BR9201452A (ko)
CA (1) CA2066508A1 (ko)
CS (1) CS119492A3 (ko)
FI (1) FI921786A (ko)
HU (1) HUT62557A (ko)
IE (1) IE921279A1 (ko)
IL (1) IL101625A0 (ko)
MX (1) MX9201808A (ko)
NO (1) NO921530L (ko)
TW (1) TW199141B (ko)
ZA (1) ZA922873B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物
JP2756732B2 (ja) * 1993-12-22 1998-05-25 ファイザー製薬株式会社 リポキシゲナーゼ阻害剤としてのフェニルチオフェニルシクロアルケニルヒドロキシ尿素
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
JP3929140B2 (ja) * 1997-10-27 2007-06-13 日本碍子株式会社 耐蝕性部材およびその製造方法
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
CN102659637B (zh) * 2012-05-21 2014-05-14 上海大学 一种制备双羟基脲的新方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE80611T1 (de) * 1985-03-16 1992-10-15 Wellcome Found Aryl-derivate.
US5185363A (en) * 1986-04-25 1993-02-09 Abbott Laboratories Urea based lipoxygenase inhibiting compounds
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
DE69004119T2 (de) * 1989-02-03 1994-03-24 Wellcome Found Entzündungshemmende Arylderivate.
JPH04504261A (ja) * 1989-03-30 1992-07-30 アボツト・ラボラトリーズ 尿素系リポキシゲナーゼ阻害化合物
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents

Also Published As

Publication number Publication date
AU638641B2 (en) 1993-07-01
CS119492A3 (en) 1992-12-16
BR9201452A (pt) 1992-12-01
IL101625A0 (en) 1992-12-30
US5283361A (en) 1994-02-01
TW199141B (ko) 1993-02-01
CA2066508A1 (en) 1992-10-24
NO921530L (no) 1992-10-26
FI921786A (fi) 1992-10-24
IE921279A1 (en) 1992-11-04
MX9201808A (es) 1994-05-31
ZA922873B (en) 1993-10-21
FI921786A0 (fi) 1992-04-22
EP0510948A1 (en) 1992-10-28
AU1500992A (en) 1992-10-29
CN1066062A (zh) 1992-11-11
HUT62557A (en) 1993-05-28
HU9201343D0 (en) 1992-07-28
JPH05117227A (ja) 1993-05-14
NO921530D0 (no) 1992-04-21

Similar Documents

Publication Publication Date Title
YU47098B (sh) Supstituisani tiazoli i njihova upotreba kao fungicida
KR920019740A (ko) 약학적 화합물
KR870003072A (ko) 아릴 피리돈의 제조방법
KR870008824A (ko) 디플루오로할로메톡시페닐 유도체 및 그것을 유효성분으로 함유하는 살비제(殺碑制)
NO913087L (no) Ny tricyklisk forbindelse eller salter derav, fremgangsmaate for fremstilling derav og antimikrobielt middel inneholdende slike.
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
DK296389D0 (da) Farmaceutiske forbindelser
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
PT865424E (pt) Pesticidas
FI901419A0 (fi) Herbicida //(1,3,5-triazin-2-yl) aminokarbonyl/aminosulfonyl/bensoesyraestrar, foerfaranden foer deras framstaellning och deras anvaendning.
KR920019739A (ko) 약학적 화합물
KR870003994A (ko) 도파민-β-하이드록시라제 억제제
ATE86259T1 (de) Antibakterielle 9-deoxy-9a-allyl und propargyl-9a-aza-9a-homoerythromycin-a-derivate
FI840353A (fi) Fungicida triazolfoereningar.
MX9206930A (es) Nuevos compuestos
KR890003718A (ko) N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
ES2073871T3 (es) Tiazolidin-2,4-dionas en el tratamiento de la hipertension.
KR890009270A (ko) 식물 보호용 살균제
JPS52131537A (en) Tickcide and fungicide
KR900701260A (ko) 2,3-디하이드로-1h-페날렌-2-아민 불안해소/우울증 방지제
BR8605329A (pt) Processo para preparacao de derivados de azolila com atividade fungicida e processo para combater infestacoes por fungos em plantas uteis
KR930000474A (ko) 벤조일 우레아 유도체
ES8303392A1 (es) Procedimiento para la obtencion de la n-2(5-dimetilamino) metil-2-furanil) metil tio etil-n-(2-etanol)-2-nitro-1,1-etenodiamina.
TH2688EX (th) สารประกอบเบนโซอิลเยูเรียที่ใช้ฆ่าตัวรังควาน

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid